EMA Boss Rasi Fields Questions Over Selection Process For Agency Home Post-Brexit
Executive Summary
A press conference following the announcement that the European Medicines Agency is to move from London to Amsterdam included a series of questions on the selection process and the voting itself.
You may also be interested in...
Dutch Defend Choice Of Amsterdam For EMA As Italy Tries To Shift Agency To Milan
The Italian government has asked the Court of Justice of the EU to annul the decision to site the European Medicines Agency in Amsterdam and wants to move the agency instead to Milan. But the Dutch government insists that the selection process was “fair” and that the need for temporary premises had been made clear all along.
EMA Relocation: EU Approval Delays Cannot Be Ruled Out
Now that the European Medicines Agency knows where it is going after Brexit, the business of preparing for the move can begin. Being able to ensure business continuity during and after the relocation from London to Amsterdam will be highly dependent on the EMA’s ability to retain as many of its current staff as possible. Job losses are expected but it could be some time before it’s clear which business operations will be affected.
EMA’s Future Home: Assessment Of Bids Nears Completion Amid Growing Staff Concerns
Sept. 30 is the date by which the European Commission must complete its assessment of member states’ bids to host the European Medicines Agency after Brexit. The agency has again highlighted the pressures it is under as a result of the relocation, and the situation has worsened after some LGBT staff members expressed concern about their rights in certain potential host countries in eastern Europe.